109 related articles for article (PubMed ID: 36711639)
1. Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of
Tian Y; Dong D; Wang Z; Wu L; Park JY; Wei GH; Wang L;
bioRxiv; 2023 May; ():. PubMed ID: 36711639
[TBL] [Abstract][Full Text] [Related]
2. Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression.
Tian Y; Dong D; Wang Z; Wu L; Park JY; ; Wei GH; Wang L
Am J Hum Genet; 2023 Aug; 110(8):1289-1303. PubMed ID: 37541187
[TBL] [Abstract][Full Text] [Related]
3. Post genome-wide association studies functional characterization of prostate cancer risk loci.
Jiang J; Cui W; Vongsangnak W; Hu G; Shen B
BMC Genomics; 2013; 14 Suppl 8(Suppl 8):S9. PubMed ID: 24564736
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
Jin HJ; Jung S; DebRoy AR; Davuluri RV
Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348
[TBL] [Abstract][Full Text] [Related]
5. Single-Nucleotide Polymorphisms Sequencing Identifies Candidate Functional Variants at Prostate Cancer Risk Loci.
Zhang P; Tillmans LS; Thibodeau SN; Wang L
Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31323811
[TBL] [Abstract][Full Text] [Related]
6. Endometrial vezatin and its association with endometriosis risk.
Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
[TBL] [Abstract][Full Text] [Related]
7. Functional genetic variants of RUVBL1 predict overall survival of Chinese patients with epithelial ovarian cancer.
Li H; Tong X; Xu Y; Wang M; Dai H; Shi T; Sun M; Chen K; Cheng X; Wei Q
Carcinogenesis; 2019 Oct; 40(10):1209-1219. PubMed ID: 31083717
[TBL] [Abstract][Full Text] [Related]
8. Functional genomic analysis delineates regulatory mechanisms of GWAS-identified bipolar disorder risk variants.
Chen R; Yang Z; Liu J; Cai X; Huo Y; Zhang Z; Li M; Chang H; Luo XJ
Genome Med; 2022 May; 14(1):53. PubMed ID: 35590387
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic insights into genetic susceptibility to prostate cancer.
Tian P; Zhong M; Wei GH
Cancer Lett; 2021 Dec; 522():155-163. PubMed ID: 34560228
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in the cholesterol biosynthesis pathway genes and risk of prostate cancer.
Cheng Y; Meng Y; Li S; Cao D; Ben S; Qin C; Hua L; Cheng G
Gene; 2021 Mar; 774():145432. PubMed ID: 33444688
[TBL] [Abstract][Full Text] [Related]
11. RUVBL1 promotes enzalutamide resistance of prostate tumors through the PLXNA1-CRAF-MAPK pathway.
Sun F; Wang X; Hu J; Liu J; Wang X; Jia W; Yu Z; Gao L; Dou B; Zhao R; Feng T; Wang X; Zhang W; Liu H; Liu K; Shao Y; Dong X; Han B
Oncogene; 2022 Jun; 41(23):3239-3250. PubMed ID: 35508542
[TBL] [Abstract][Full Text] [Related]
12. Combined SNPs sequencing and allele specific proteomics capture reveal functional causality underpinning the 2p25 prostate cancer susceptibility locus.
Wei GH; Dong D; Zhang P; Liu M; Wei Y; Wang Z; Xu W; Zhang Q; Zhu Y; Zhang Q; Yang X; Zhu J; Wang L
Res Sq; 2024 Apr; ():. PubMed ID: 38645058
[TBL] [Abstract][Full Text] [Related]
13. Novel role of prostate cancer risk variant rs7247241 on PPP1R14A isoform transition through allelic TF binding and CpG methylation.
Tian Y; Soupir A; Liu Q; Wu L; Huang CC; Park JY; Wang L
Hum Mol Genet; 2022 May; 31(10):1610-1621. PubMed ID: 34849858
[TBL] [Abstract][Full Text] [Related]
14. Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci.
Chen H; Yu H; Wang J; Zhang Z; Gao Z; Chen Z; Lu Y; Liu W; Jiang D; Zheng SL; Wei GH; Issacs WB; Feng J; Xu J
Prostate; 2015 Sep; 75(12):1264-76. PubMed ID: 26015065
[TBL] [Abstract][Full Text] [Related]
15. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
[TBL] [Abstract][Full Text] [Related]
16. RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers.
Lin D; Lin B; Bhanot H; Riou R; Abt NB; Rajagopal J; Saladi SV
Oral Oncol; 2020 Dec; 111():104930. PubMed ID: 32745900
[TBL] [Abstract][Full Text] [Related]
17. Functional genomics elucidates regulatory mechanisms of Parkinson's disease-associated variants.
Chen R; Liu J; Li S; Li X; Huo Y; Yao YG; Xiao X; Li M; Luo XJ
BMC Med; 2022 Feb; 20(1):68. PubMed ID: 35168626
[TBL] [Abstract][Full Text] [Related]
18. Massively parallel reporter assays and variant scoring identified functional variants and target genes for melanoma loci and highlighted cell-type specificity.
Long E; Yin J; Funderburk KM; Xu M; Feng J; Kane A; Zhang T; Myers T; Golden A; Thakur R; Kong H; Jessop L; Kim EY; Jones K; Chari R; Machiela MJ; Yu K; ; Iles MM; Landi MT; Law MH; Chanock SJ; Brown KM; Choi J
Am J Hum Genet; 2022 Dec; 109(12):2210-2229. PubMed ID: 36423637
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide and parental allele-specific analysis of CTCF and cohesin DNA binding in mouse brain reveals a tissue-specific binding pattern and an association with imprinted differentially methylated regions.
Prickett AR; Barkas N; McCole RB; Hughes S; Amante SM; Schulz R; Oakey RJ
Genome Res; 2013 Oct; 23(10):1624-35. PubMed ID: 23804403
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival.
Li W; Middha M; Bicak M; Sjoberg DD; Vertosick E; Dahlin A; Häggström C; Hallmans G; Rönn AC; Stattin P; Melander O; Ulmert D; Lilja H; Klein RJ
Eur Urol; 2018 Dec; 74(6):710-719. PubMed ID: 30289108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]